Jehn U, Altuner U, Pavenstadt H, Reuter S, et al. First Report on Successful Conversion of Long-Term Treatment of Recurrent Atypical Hemolytic Uremic Syndrome With Eculizumab to Ravulizumab in a Renal Transplant Patient. Transpl Int 2022;35:10846.
PMID: 36262114